CHEINY SHIAU: Open Payments
NPI 1477036895 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$38,056 in 356 payments from 21 companies in 2025. Trend: 2023 $12,001 · 2024 $29,597 · 2025 $38,056
Speaker / faculty: $27,717Food & beverage: $8,356Travel & lodging: $1,883Education: $99
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 71 | $13,643 |
| ABBVIE INC. | 97 | $12,180 |
| Galderma Laboratories, L.P. | 26 | $7,738 |
| GENZYME CORPORATION | 15 | $809 |
| Novartis Pharmaceuticals Corporation | 22 | $612 |
| Arcutis Biotherapeutics, Inc. | 16 | $436 |
| E.R. Squibb & Sons, L.L.C. | 19 | $345 |
| Lilly USA, LLC | 13 | $336 |
| Janssen Biotech, Inc. | 15 | $313 |
| LEO Pharma Inc. | 13 | $303 |
Products named: Bimzelx, NEMLUVIO, SKYRIZI, RINVOQ, DUPIXENT, Zoryve, Sotyktu, TREMFYA.
Industry payments across CA — which companies pay providers there.
